Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?

被引：0
|
作者：
Qin, Kirby R. [1 ,2 ,3 ]
Mertens, Eveline [1 ]
Tempo, Jake A. [4 ]
Perera, Marlon [4 ]
Brennan, Janelle [1 ,2 ]
机构：
[1] Bendigo Hlth, Dept Urol, 100 Barnard St, Bendigo, Vic 3550, Australia
[2] Monash Univ, Sch Rural Hlth, Bendigo, Vic, Australia
[3] Monash Univ, Dept Paediat, Melbourne, Vic, Australia
[4] Austin Hlth, Dept Urol, Melbourne, Vic, Australia
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 05期
关键词：
D O I：
10.21037/tau-24-12
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：920 / 922
页数：3
相关论文
共 50 条
  • [21] Prevalence and impact of vasomotor symptoms due to menopause: Canadian subgroup of the Women with Vasomotor Symptoms Associated With Menopause (WARM) study
    Yuksel, Nese
    Todorova, Lora
    Scrine, Ludmila
    Rea, Carol
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1305 - 1305
  • [22] EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY FOR VASOMOTOR SYMPTOMS IN MENOPAUSE
    Fawad, Anisa
    Danish, Nargis
    [J]. GOMAL JOURNAL OF MEDICAL SCIENCES, 2008, 6 (01):
  • [23] Nonestrogen treatment modalities for vasomotor symptoms associated with menopause
    Fugate, SE
    Church, CO
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1482 - 1499
  • [24] NONPHARMACOLOGIC TREATMENTS FOR MENOPAUSE-ASSOCIATED VASOMOTOR SYMPTOMS
    Goldstein, Karen M.
    Coeytaux, Remy
    Shepherd-Banigan, Megan
    Goode, Adam
    McDuffie, Jennifer
    Befus, Deanna
    Adam, Soheir
    Masilamani, Varsha
    Van Noord, Megan
    Williams, John
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S254 - S255
  • [25] Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
    Elnaga, Ahmed A. Abo
    Alsaied, Mohamed A.
    Elettreby, Abdelrahman M.
    Ramadan, Alaa
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 297 : 142 - 152
  • [26] The relationship between vasomotor symptoms and menopause-associated dizziness
    Owada, Satoko
    Suzuki, Mitsuya
    [J]. ACTA OTO-LARYNGOLOGICA, 2014, 134 (02) : 146 - 150
  • [27] Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)
    Ruan, Xiangyan
    Bai, Wenpei
    Ren, Mulan
    Kim, Tak
    Lee, Ji Young
    Chuang, Fei-Chi
    Wang, Peng-Hui
    He, Weizhong
    Ma, Xiao
    Miyazaki, Kentaro
    Song, Nan
    Wang, Xuegong
    Yu, Qi
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (05)
  • [28] Early response with fezolinetant treatment of moderate-to-severe vasomotor symptoms associated with menopause: pooled data from two randomized Phase 3 studies
    Shapiro, C. M. Marla
    Neal-Perry, Genevieve
    Stute, Petra
    Thurston, Rebecca C.
    Wolfman, Wendy
    English, Marci
    Zhao, Jun
    Ottery, Faith D.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1483 - 1484
  • [29] Androgen deprivation therapy associated with depression
    [J]. Reactions Weekly, 2016, 1598 (1) : 8 - 8
  • [30] Androgen deprivation therapy associated with dementia?
    [J]. Reactions Weekly, 2016, 1630 (1) : 4 - 4
12345